menu search

Precipio’s omnia™ methodology enables diagnosis of mds with peripheral blood instead of bone marrow biopsy

Use of HemeScreen® technology enables diagnosis without the need for painful, invasive sampling NEW HAVEN, Conn., June 14, 2023 (GLOBE NEWSWIRE) — ...

June 14, 2023, 1:49 pm

Correction — precipio continues to sign up and onboard hemescreen™ customers

Conversion from sales funnels developed with distribution partners alongside direct sales points to continued accelerated growth NEW HAVEN, Conn., Mar...

March 7, 2023, 5:49 pm

Precipio continues to sign up and onboard hemescreen™ customers

Conversion from sales funnels developed with distribution partners alongside direct sales points to continued accelerated growth NEW HAVEN, Conn., Mar...

March 7, 2023, 5:00 pm


Search within

Pages Search Results: